BABAK, O. Y.; LAPSHYNA, K. A. The fibroblasts growth factor 21 study in patients with non-alcoholic fatty liver disease and hypertension comorbidities. Zaporozhye Medical Journal, [S. l.], v. 22, n. 2, 2020. DOI: 10.14739/2310-1210.2020.2.200572. Disponível em: http://zmj.zsmu.edu.ua/article/view/200572. Acesso em: 23 nov. 2024.